Rezivertinib (Standard)

(Synonyms: BPI-7711 (Standard))

Rezivertinib (Standard) is the analytical standard of Rezivertinib (HY-109189). This product is intended for research and analytical applications. Rezivertinib (BPI-7711) is an orally active, highly selective and irreversible third-generation EGFR tyrosine Kinase inhibitor (TKi). Rezivertinib exhibits high potency against the common activation EGFR and the resistance T790M mutations. Rezivertinib has excellent central nervous system (CNS) penetration and has antitumor activity.

For research use only. We do not sell to patients.

  • CAS No.: 1835667-12-3
  • Formula: C27H30N6O3
  • Molecular Weight:486.57
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Product Information
  • Chemical Information
  • Purity & Documentation
  • Help & FAQs
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00